furosemide has been researched along with acetaminophen in 83 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (26.51) | 18.7374 |
1990's | 3 (3.61) | 18.2507 |
2000's | 24 (28.92) | 29.6817 |
2010's | 26 (31.33) | 24.3611 |
2020's | 8 (9.64) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Botta, M; Dreassi, E; Falchi, F; Maga, G; Santucci, A; Schenone, S; Zizzari, AT | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Akamatsu, M | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Richens, A | 1 |
Jollow, DJ; Mitchell, JR; Potter, WZ; Sasame, HA; Thorgeirsson, SS | 1 |
Mitchell, JR; Potter, WZ; Sasame, HA; Thorgeirsson, SS | 1 |
Dybing, E | 3 |
Mitchell, JR; Potter, WZ | 1 |
Dybing, E; Mitchell, JR | 1 |
Levine, L | 1 |
D'Angelo, LJ | 1 |
Dybing, E; McMurtry, RJ; Mitchell, JR; Nelson, SD; Thorgeirsson, SS | 1 |
McMurtry, RJ; Mitchell, JR; Nelson, SD; Statham, CN | 1 |
Gillette, JR; Mitchell, JR; Snodgrass, WR | 1 |
Jollows, DJ; Mitchell, JR | 1 |
Cefalo, RC; Katz, VL; Peterson, R | 1 |
Adamson, GM; Harman, AW | 1 |
Bock, GR; Miller, JJ; Moorjani, PA | 1 |
Gillette, JR | 2 |
Hughes, H; Mitchell, JR; Smith, CV | 1 |
D'Arcy, PF | 1 |
Kern, F; Mallory, A | 1 |
de Villiers, MM | 1 |
Martin, U; Prescott, LF | 1 |
Hayball, PJ; Henderson, G; Latimer, K; May, F; Rowett, D; Ruffin, RE; Sansom, LN | 1 |
Rogers, LK; Smith, CV; Szczpyka, M; Valentine, CJ | 1 |
Casalderrey, M; Concheiro, A; Gómez-Amoza, JL; Martínez-Pacheco, R; Souto, C | 1 |
Bruculeri, C; Chou, A; Dobrogowska, A; Dontabhaktuni, A; Lam, TS; Lee, H; Manolas, T; Mohammad, S; Patel, C; Patel, R; Patel, S; Phadke, S; Ray, SD; Rotollo, JA; Stohs, S; Strika, S | 1 |
Bhattachar, SN; Fioritto, AF; Wesley, JA | 1 |
Kaukonen, AM; Laitinen, L; Marvola, M; Takala, E; Vuorela, H; Vuorela, P | 1 |
Benson, CA; Goldring, CE; Kitteringham, NR; Metcalfe, PN; Park, BK; Randle, LE; Williams, DP | 1 |
Masumoto, H; Mitsuru, A; Okazaki, O; Sudo, K; Takakusa, H | 1 |
Castellano, PM; Kaufman, TS; Maggio, RM | 1 |
Abazia, DT; Marcus, A; Ross, J; Sachinwalla, E; Smolarz, BG | 1 |
Masubuchi, Y; Nakayama, J; Sadakata, Y | 1 |
Ghanam, D; Kleinebudde, P | 1 |
Bryant, SC; Gastineau, DA; Greiner, CW; Hogan, WJ; Jacob, EK; Lingineni, RK; Mohr, A; Mulay, SB; Padley, D | 1 |
Bogomolov, VV; Kondratenko, SN; Kovachevich, IV | 1 |
Barcellini-Couget, S; de Sousa, G; Luzy, AP; Peyre, L; Rahmani, R; Zucchini-Pascal, N | 1 |
Ros Forteza, FJ | 1 |
Bonsante, F; Gambacorta, S; Gouyon, B; Gouyon, JB; Iacobelli, S; Laforgia, N; Lorrain, S | 1 |
Aubrecht, J; Boucher, GG; Church, RJ; Eaddy, JS; Kreeger, JM; Schomaker, SJ; Watkins, PB | 1 |
Al Ansari, E; Al Jufairi, M; Al Madhoob, A; Al Marzooq, R; Sridharan, K | 1 |
Elenga, N; Fremery, A; Geoffroy, S; Lambert, Y; Marty, C | 1 |
Al Ansari, E; Al Jufairi, M; Al Madhoob, A; Al Marzooq, R; Al Segai, O; Hashem Ahmed, H; Husain Shaban, G; Malalla, Z; Saeed Tabbara, K; Sridharan, K | 1 |
Badriddinova, LY; Kondratenko, SN; Kovachevich, IV; Polyakov, AV; Repenkova, LG; Savelyeva, MI; Shikh, EV; Svistunov, AA | 1 |
Correia, AT; Guimarães, LL; Roveri, V; Toma, W | 1 |
Armanious, H; Bristow, E; Dinakaran, D; Garros, D; Noga, M; Sergi, C; Yap, J | 1 |
Ajaz, M; Akram, M; Asif, HM; Daniyal, M; Hussain, A; Khan, FS; Shah, SMA; Tahir, IM | 1 |
9 review(s) available for furosemide and acetaminophen
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Interactions with antiepileptic drugs.
Topics: Acetaminophen; Acetazolamide; Anti-Anxiety Agents; Anticoagulants; Anticonvulsants; Carbamazepine; Diazepam; Drug Interactions; Furosemide; Gonadal Steroid Hormones; Griseofulvin; Humans; Phenobarbital; Phenytoin; Primidone; Thiazines; Urea; Valproic Acid; Vitamin D | 1977 |
Drug metabolism in the production of liver injury.
Topics: Acetaminophen; Acetanilides; Alkylating Agents; Bromobenzenes; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Drug Hypersensitivity; Ethers; Furosemide; Glutathione; Halothane; Humans; Inactivation, Metabolic; Isoniazid; Liver; Liver Neoplasms; Necrosis; Pharmaceutical Preparations; Phenacetin; Protein Binding; Thiophenes | 1975 |
Reported ocular side effects of the ten most frequently prescribed drugs.
Topics: Acetaminophen; Ampicillin; Brompheniramine; Codeine; Diazepam; Digoxin; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Eye; Eye Diseases; Female; Furosemide; Humans; Hydrochlorothiazide; Methyldopa; Phenylephrine; Phenylpropanolamine; Pregnancy; Propranolol; Tetracyclines; Triamterene | 1979 |
Metabolic activation: biochemical basis for many drug-induced liver injuries.
Topics: Acetaminophen; Animals; Binding Sites; Carcinogens; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Furosemide; Humans; Hydrazines; Isoniazid; Liver; Methyldopa; Necrosis; Pharmaceutical Preparations; Phenacetin; Thiophenes | 1976 |
The problem of chemically reactive metabolites.
Topics: Acetaminophen; Animals; Biotransformation; Chemical Phenomena; Chemistry; Chloroform; Drug-Related Side Effects and Adverse Reactions; Furosemide; Humans; Isoniazid; Kinetics; Pharmaceutical Preparations; Terpenes | 1982 |
Drug-induced pancreatitis: a critical review.
Topics: Acetaminophen; Adrenal Cortex Hormones; Amphetamines; Asparaginase; Azathioprine; Chlorthalidone; Cholestyramine Resin; Cimetidine; Cyproheptadine; Dextropropoxyphene; Diazoxide; Diuretics; Estrogens; Ethacrynic Acid; Furosemide; Histamine; Humans; Hypercalcemia; Indomethacin; Isoniazid; Mercaptopurine; Narcotics; Pancreatitis; Phenformin; Procainamide; Rifampin; Salicylates; Sodium Chloride Symporter Inhibitors; Sulfonamides; Tetracycline | 1980 |
2 trial(s) available for furosemide and acetaminophen
Article | Year |
---|---|
The interaction of paracetamol with frusemide.
Topics: 6-Ketoprostaglandin F1 alpha; Acetaminophen; Adult; Dinoprostone; Diuresis; Drug Interactions; Female; Furosemide; Humans; Middle Aged; Natriuresis; Radioimmunoassay; Renin | 1994 |
The effect of hypoxaemia on drug disposition in chronic respiratory failure.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Biological Availability; Chronic Disease; Cross-Over Studies; Female; Furosemide; Humans; Hypoglycemic Agents; Hypoxia; Male; Middle Aged; Oxygen Consumption; Protein Binding; Respiratory Insufficiency | 1996 |
72 other study(ies) available for furosemide and acetaminophen
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.
Topics: Humans; Lipids; Membranes, Artificial; Permeability; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrazoles; Pyrimidines | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Biochemical changes after hepatic injury from toxic doses of acetaminophen or furosemide.
Topics: Acetaminophen; Aniline Hydroxylase; Animals; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Endoplasmic Reticulum; Ethylmorphine-N-Demethylase; Furosemide; Glucose-6-Phosphatase; Glucuronosyltransferase; Liver; Male; Mice; Microsomes, Liver; Proteins | 1976 |
Biochemical changes after hepatic injury by allyl alcohol and N-hydroxy-2-acetylaminofluorene.
Topics: Acetaminophen; Allyl Compounds; Aniline Hydroxylase; Animals; Carbon Tetrachloride; Cytochrome P-450 Enzyme System; Cytochromes; Cytosol; Dimethylnitrosamine; Ethylmorphine-N-Demethylase; Fluorenes; Furosemide; Glucose-6-Phosphatase; Hydroxyacetylaminofluorene; Liver; Liver Regeneration; Male; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Nitrogenase; Proteins; Rats | 1976 |
Methyldopa binding to cells in culture.
Topics: Acetaminophen; Allopurinol; Animals; Ascorbic Acid; Carcinoma, Hepatocellular; Cells, Cultured; Deferoxamine; Dimethylnitrosamine; Edetic Acid; Furosemide; Glutathione; Liver Neoplasms; Maleates; Methyldopa; Neoplasms, Experimental; Protein Binding; Rats; Superoxide Dismutase; Time Factors; Xanthines | 1977 |
The role of metabolic activation for drug-induced liver injuries.
Topics: Acetaminophen; Chemical and Drug Induced Liver Injury; Furosemide; Humans; Isoniazid; Liver; Methyldopa | 1977 |
Oxacillin and hepatotoxicity.
Topics: Acetaminophen; Chemical and Drug Induced Liver Injury; Furosemide; Humans; Meprobamate; Oxacillin; Prochlorperazine | 1979 |
Activation of alpha-methyldopa, paracetamol and furosemide by human liver microsomes.
Topics: Acetaminophen; Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Furosemide; Humans; Methyldopa; Microsomes, Liver | 1977 |
Molecular basis for several drug-induced nephropathies.
Topics: Acetaminophen; Analgesics; Animals; Carbon Tetrachloride Poisoning; Cephaloridine; Chloroform; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Furosemide; Glutathione; Humans; Kidney; Kidney Diseases; Kidney Tubular Necrosis, Acute; Kidney Tubules, Proximal; Protein Binding; Salicylates; Toxicology | 1977 |
The role of biotransformation in chemical-induced liver injury.
Topics: Acetaminophen; Animals; Biotransformation; Bromobenzenes; Chemical and Drug Induced Liver Injury; Cricetinae; Furosemide; Glutathione; Guinea Pigs; Humans; In Vitro Techniques; Iproniazid; Isoniazid; Liver Diseases; Methylcholanthrene; Mice; Phenobarbital; Rats | 1976 |
Progress in hepatology. Metabolic activation of drugs to toxic substances.
Topics: Acetaminophen; Animals; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry; Cricetinae; Furosemide; Hemolysis; Humans; Isoniazid; Kidney Diseases; Kinetics; Liver; Lung Diseases; Mice; Protein Binding; Toxicology; Tritium | 1975 |
[Drug induced liver injury. Chemical liver necrosis caused by formation of reactive metabolites].
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Furosemide; Humans; Isoniazid; Liver; Methyldopa; Necrosis | 1976 |
Pseudotumor cerebri and pregnancy.
Topics: Acetaminophen; Acetazolamide; Codeine; Female; Furosemide; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Pseudotumor Cerebri; Tomography, X-Ray Computed | 1989 |
Comparison of the susceptibility of hepatocytes from postnatal and adult mice to hepatotoxins.
Topics: Acetaminophen; Aging; Animals; Animals, Newborn; Catalase; Furosemide; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Iodoacetates; Iodoacetic Acid; L-Lactate Dehydrogenase; Liver; Peroxides; Superoxide Dismutase; tert-Butylhydroperoxide; Time Factors | 1988 |
The effects of paracetamol on frusemide ototoxicity.
Topics: Acetaminophen; Action Potentials; Animals; Auditory Threshold; Dose-Response Relationship, Drug; Drug Interactions; Furosemide; Guinea Pigs; Time Factors | 1985 |
Commentary. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactivity metabolites with changes in the incidence and severity of toxicity.
Topics: Acetaminophen; Animals; Autoradiography; Benzene Derivatives; Carbon Tetrachloride Poisoning; Carcinogens; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry; Culture Techniques; Drug Stability; Furosemide; Hydrocarbons, Halogenated; Kinetics; Liver; Mutagens; Necrosis; Toxicology | 1974 |
Free radicals in vivo. Covalent binding to lipids.
Topics: Acetaminophen; Animals; Bromobenzenes; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry; Dimethylnitrosamine; Free Radicals; Furans; Furosemide; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains | 1984 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
Influence of cohesive properties of micronized drug powders on particle size analysis.
Topics: Acetaminophen; Chemical Phenomena; Chemistry, Physical; Chloramphenicol; Drug Compounding; Furosemide; Microscopy, Electron, Scanning; Particle Size; Powders; Surface Properties | 1995 |
Effects of hepatotoxic doses of acetaminophen and furosemide on tissue concentrations of CoASH and CoASSG in vivo.
Topics: Acetaminophen; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Coenzyme A; Disease Models, Animal; Furosemide; Glutathione; Liver; Male; Mass Spectrometry; Mice; Mice, Inbred ICR | 2000 |
A comparison of drug loading capacity of cellactose with two ad hoc processed lactose-cellulose direct compression excipients.
Topics: Acetaminophen; Cellulose; Diuretics; Drug Compounding; Excipients; Furosemide; Kinetics; Lactose; Mercury; Particle Size; Porosity; Solubility; Surface Properties; Tablets; Tensile Strength | 2004 |
Oxidative stress is the master operator of drug and chemically-induced programmed and unprogrammed cell death: Implications of natural antioxidants in vivo.
Topics: Acetaminophen; Administration, Oral; Animals; Antioxidants; Apoptosis; Cell Death; Furosemide; Liver; Male; Mice; Mice, Inbred ICR; Oxidative Stress; Phytotherapy; Plant Extracts; Reactive Oxygen Species | 2004 |
Solubility measurement of polymorphic compounds via the pH-metric titration technique.
Topics: Acetaminophen; Acetazolamide; Chlorpropamide; Crystallography, X-Ray; Fluoroquinolones; Furosemide; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Potentiometry; Pyrroles; Quinolones; Solubility; Sulfamethoxazole; Sulfathiazole; Sulfathiazoles; Thermodynamics; Titrimetry | 2007 |
Anthranoid laxatives influence the absorption of poorly permeable drugs in human intestinal cell culture model (Caco-2).
Topics: Absorption; Acetaminophen; Anthraquinones; Beverages; Caco-2 Cells; Carbon Radioisotopes; Cathartics; Cell Membrane Permeability; Digoxin; Furosemide; Humans; Ketoprofen; Mannitol; Plant Leaves; Propranolol; Senna Extract; Sennosides; Verapamil | 2007 |
Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice.
Topics: Acetaminophen; Adaptor Proteins, Signal Transducing; Alanine Transaminase; Analysis of Variance; Animals; Blotting, Western; Bromobenzenes; Carbon Tetrachloride; Cell Nucleus; Cytoskeletal Proteins; Furosemide; Glutamate-Cysteine Ligase; Glutathione; Heme Oxygenase-1; Injections, Intraperitoneal; Kelch-Like ECH-Associated Protein 1; Liver; Male; Mice; Molecular Structure; NF-E2-Related Factor 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Xenobiotics | 2008 |
Markers of electrophilic stress caused by chemically reactive metabolites in human hepatocytes.
Topics: Acetaminophen; Aspirin; Butylated Hydroxyanisole; Carboxylic Ester Hydrolases; Cells, Cultured; Clozapine; Diclofenac; Furosemide; Glucuronosyltransferase; Heme Oxygenase-1; Hepatocytes; Humans; L-Lactate Dehydrogenase; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; RNA, Messenger; Ticlopidine; Ticrynafen | 2008 |
A new principal component analysis-based approach for testing "similarity" of drug dissolution profiles.
Topics: Acetaminophen; Furosemide; Pharmaceutical Preparations; Principal Component Analysis; Solubility; Tablets | 2008 |
Noncardiogenic pulmonary edema in a patient receiving vancomycin and oxycodone-acetaminophen.
Topics: Acetamides; Acetaminophen; Analgesics; Anti-Infective Agents; Cellulitis; Diphenhydramine; Drug Combinations; Famotidine; Furosemide; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Oxycodone; Pulmonary Edema; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Protective effects of exogenous glutathione and related thiol compounds against drug-induced liver injury.
Topics: Acetaminophen; Acetylcysteine; Animals; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Female; Furosemide; Glutathione; Interleukin-6; Liver; Male; Mice; Mice, Inbred Strains | 2011 |
Suitability of a flat die press for the manufacture of pharmaceutical pellets by extrusion/spheronization.
Topics: Acetaminophen; Chemistry, Pharmaceutical; Furosemide; Hydrochlorothiazide; Particle Size; Solubility; Technology, Pharmaceutical; Tensile Strength; Theophylline | 2011 |
Infusion technique of hematopoietic progenitor cells and related adverse events (CME).
Topics: Acetaminophen; Adolescent; Adult; Aged; Blood Preservation; Child; Child, Preschool; Cryopreservation; Cryoprotective Agents; Dimethyl Sulfoxide; Diphenhydramine; Flushing; Furosemide; Hematologic Neoplasms; Humans; Hydrocortisone; Hypertension; Infant; Infant, Newborn; Infusions, Intravenous; Isotonic Solutions; Middle Aged; Nausea; Neutrophils; Peripheral Blood Stem Cell Transplantation; Premedication; Retrospective Studies; Risk Factors; Syringes; Young Adult | 2014 |
[TESTING STABILITY OF TABLETED ACETAMINOPHEN AND FUROSEMIDE AFTER 6-MONTH STORAGE IN SPACE FLIGHT].
Topics: Acetaminophen; Drug Storage; Furosemide; Humans; Materials Testing; Space Flight; Spacecraft; Tablets; Weightlessness | 2015 |
High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity.
Topics: Acetaminophen; Amodiaquine; Animals; Carbamazepine; Cell Line, Tumor; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Diethylstilbestrol; Erythromycin; Furosemide; Hepatocytes; High-Throughput Screening Assays; Male; Neutral Red; Rats; Toxicity Tests; Tretinoin | 2015 |
Alzheimer disease triggered by reversible posterior leukoencephalopathy syndrome.
Topics: Acetaminophen; Aged; Alzheimer Disease; Analgesics, Non-Narcotic; Antihypertensive Agents; Captopril; Diuretics; Female; Furosemide; Headache; Humans; Hypertension; Magnetic Resonance Imaging; Photophobia; Posterior Leukoencephalopathy Syndrome; Sex Factors; Spain | 2020 |
Drug exposure for PDA closure in France: a prospective, cohort-based, analysis.
Topics: Acetaminophen; Administration, Oral; Drug Resistance; Drug Utilization; Ductus Arteriosus, Patent; Female; France; Furosemide; Hospitalization; Humans; Ibuprofen; Indomethacin; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Male; Practice Patterns, Physicians'; Prospective Studies; Treatment Outcome | 2020 |
Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse.
Topics: Acetaminophen; Alanine Transaminase; Animals; Biomarkers; Chemical and Drug Induced Liver Injury; Furosemide; Glutamate Dehydrogenase; Hepatocytes; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Mitophagy | 2020 |
Intravenous frusemide does not interact pharmacodynamically with acetaminophen in critically ill preterm neonates with patent ductus arteriosus.
Topics: Acetaminophen; Administration, Intravenous; Critical Illness; Ductus Arteriosus, Patent; Female; Furosemide; Humans; Infant, Premature; Male; Prospective Studies | 2021 |
Case Report: Acute Kidney Failure due to Massive Envenomation of a Two-Year-Old Child Caused by Killer Bee Stings.
Topics: Acetaminophen; Acute Kidney Injury; Analgesics, Non-Narcotic; Animals; Bee Venoms; Bees; Child, Preschool; Chlorpheniramine; Female; French Guiana; Furosemide; Glucocorticoids; Histamine H1 Antagonists; Humans; Insect Bites and Stings; Prednisolone | 2021 |
Biomarkers in neonates receiving potential nephrotoxic drugs.
Topics: Acetaminophen; Adult; Amikacin; Biomarkers; Cystatins; Female; Furosemide; Gentamicins; Hepatitis A Virus Cellular Receptor 1; Humans; Ibuprofen; Infant, Newborn; Kidney Diseases; Lipocalin-2; Male; Middle Aged; Vancomycin | 2021 |
Study of the pharmacokinetics of various drugs under conditions of antiorthostatic hypokinesia and the pharmacokinetics of acetaminophen under long-term spaceflight conditions.
Topics: Acetaminophen; Furosemide; Humans; Hypokinesia; Pharmaceutical Preparations; Propranolol; Space Flight; Verapamil | 2021 |
Occurrence, ecological risk assessment and prioritization of pharmaceuticals and abuse drugs in estuarine waters along the São Paulo coast, Brazil.
Topics: Acetaminophen; Atenolol; Brazil; Caffeine; Carbamazepine; Chromatography, Liquid; Cocaine; Diclofenac; Ecosystem; Environmental Monitoring; Furosemide; Illicit Drugs; Losartan; Orphenadrine; Pharmaceutical Preparations; Risk Assessment; Rivers; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2022 |
Co-ingestion of willow bark tea and acetaminophen associated with fatal infantile fulminant liver failure.
Topics: Acetaminophen; Antipyretics; Child, Preschool; Fatal Outcome; Humans; Liver Failure, Acute; Male; Medicine, Traditional; Plant Bark; Salix; Tea | 2017 |
Phytochemical screening and antipyretic effects of hydroalcoholic extracts of selected medicinal plants of Rawalakot, Azad Jammu and Kashmir in albino rats.
Topics: Acetaminophen; Achillea; Animals; Antipyretics; Drug Evaluation, Preclinical; Female; Fever; Male; Pakistan; Phytochemicals; Plant Extracts; Plants, Medicinal; Rats; Salix; Taraxacum; Trigonella | 2019 |